πŸ”¬ KFT & LFT IN GASTROENTEROLOGY DISORDERS

🦠 CASE 1: HEPATORENAL SYNDROME (HRS) IN CIRRHOSIS

πŸ“Œ Clinical Scenario:

A 58-year-old male with decompensated cirrhosis (due to hepatitis C) presents with ascites, jaundice, confusion, oliguria, and hypotension.

πŸ“Š KFT & LFT REPORTS:

TestValueNormal RangeInterpretation
Bilirubin (Total)9.2 mg/dL0.1 – 1.2 mg/dLSevere jaundice
ALT (SGPT)65 U/L7 – 56 U/LLiver dysfunction
AST (SGOT)90 U/L10 – 40 U/LAlcoholic liver damage
INR (Coagulation)2.2<1.1Liver failure, coagulopathy
Ammonia (Plasma)180 Β΅mol/L15 – 45 Β΅mol/LHepatic encephalopathy
Creatinine3.5 mg/dL0.6 – 1.2 mg/dLHepatorenal Syndrome (Type 1)
BUN65 mg/dL7 – 20 mg/dLAcute kidney injury
Urine Sodium<10 mEq/L20 – 40 mEq/LPre-renal failure

πŸ“ Diagnosis:

  • Hepatorenal Syndrome (Type 1) due to End-Stage Liver Disease

βœ… Management:

  • IV Albumin + Vasopressors (Terlipressin)
  • Paracentesis with Albumin Infusion for ascites
  • Consider Liver Transplant (Definitive Treatment)

🦠 CASE 2 : CHOLESTATIC LIVER DISEASE WITH NEPHROTIC SYNDROME

πŸ“Œ Clinical Scenario:

A 47-year-old female with primary biliary cholangitis (PBC) presents with pruritus, jaundice, and lower limb edema.

πŸ“Š KFT & LFT REPORTS:

TestValueNormal RangeInterpretation
Bilirubin (Total)5.0 mg/dL0.1 – 1.2 mg/dLObstructive jaundice
Alkaline Phosphatase (ALP)420 U/L44 – 147 U/LCholestatic disease
GGT (Gamma-GT)310 U/L9 – 48 U/LBiliary dysfunction
Creatinine2.5 mg/dL0.6 – 1.2 mg/dLNephrotic syndrome due to PBC
Urine Protein/Creatinine Ratio4.6 g/g<0.2 g/gSevere proteinuria
Albumin (Serum)2.0 g/dL3.4 – 5.4 g/dLHypoalbuminemia

πŸ“ Diagnosis:

  • Primary Biliary Cholangitis (PBC) with Secondary Nephrotic Syndrome

βœ… Management:

  • Ursodeoxycholic Acid (UDCA) for cholestasis
  • ACE Inhibitors for proteinuria
  • Diuretics (Spironolactone) for edema

⚠️ CASE 3: ACUTE PANCREATITIS WITH SECONDARY KIDNEY INJURY

πŸ“Œ Clinical Scenario:

A 38-year-old male with a history of gallstones presents with severe epigastric pain radiating to the back, nausea, vomiting, and oliguria.

πŸ“Š KFT & LFT REPORTS:

TestValueNormal RangeInterpretation
Serum Lipase780 U/L<160 U/LSevere pancreatitis
ALT (SGPT)130 U/L7 – 56 U/LBiliary obstruction
AST (SGOT)110 U/L10 – 40 U/LHepatocellular injury
Bilirubin (Total)2.2 mg/dL0.1 – 1.2 mg/dLCholestasis
Creatinine3.0 mg/dL0.6 – 1.2 mg/dLAcute kidney injury (AKI)
BUN58 mg/dL7 – 20 mg/dLPrerenal azotemia
Calcium (Serum)6.5 mg/dL8.5 – 10.5 mg/dLSaponification (Fat Necrosis)

πŸ“ Diagnosis:

  • Acute Pancreatitis (Gallstone-Induced) with Secondary Acute Kidney Injury

βœ… Management:

  • Aggressive IV Fluids (Ringer’s Lactate) for AKI
  • NPO (Nil per Os) + NG Tube for pancreatitis
  • Pain Control (IV Opioids) & Electrolyte Correction

πŸ”¬ CLINICAL INTEGRATION OF KFT & LFT IN GI DISORDERS

ConditionKFT FindingsLFT Findings
Hepatorenal Syndrome (HRS)↑ Creatinine, ↓ Urine Sodium↑ Bilirubin, ↑ INR, ↑ Ammonia
Primary Biliary Cholangitis (PBC) + Nephrotic Syndrome↑ Creatinine, Proteinuria↑ ALP, ↑ GGT, ↑ Bilirubin
Acute Pancreatitis with Kidney Injury↑ Creatinine, ↑ BUN↑ ALT, ↑ AST, ↑ Lipase

πŸ“Œ FOR CLINICAL PRACTICE

  1. In cirrhosis, monitor both KFT & LFT to detect hepatorenal syndrome early.
  2. Cholestatic diseases (e.g., PBC) can cause secondary renal dysfunction.
  3. Acute pancreatitis can cause AKI due to hypovolemia and systemic inflammation.

Total Number of Words: 390

Total Reading Time: 1 minutes 58 seconds